Source Paper
PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation
J. Grayson Richards, Guy A. Higgins, Abdel-Mouttalib Ouagazzal, Laurence Ozmen, James N. C. Kew et al.
Journal of Neuroscience • 2003
Behavioral Testing
Objective: Assessment of age-related cognitive deficits in PS2APP transgenic mice at multiple time points (4, 8, 12, and 16 months) and investigation of changes in behavior, electrophysiology, amyloid-beta load, histopathology, and immunoelectron microscopy
This is a Behavioral Testing protocol using mouse as the model organism. The procedure involves 5 procedural steps. Extracted from a 2003 paper published in Journal of Neuroscience.
Model and subjects
mouse • PS2APP transgenic (PS2 N141I × APP swe) • unknown • 4, 8, 12, and 16 months • Not specified
Study window
Estimated timing pending
Core workflow
Behavioral Testing • Electrophysiology Assessment • ELISA Analysis for Aβ Load
Primary readouts
- Behavioral changes across age cohorts
- Cognitive deficits
- Synapse efficacy (electrophysiology)
- Amyloid-beta load (Aβ 1-40 and Aβ 1-42 levels)
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Behavioral Testing
Conduct behavioral assessment of PS2APP transgenic mice at each age cohort
Note: Testing performed at 4, 8, 12, and 16 months of age
View evidence from paper
“Each age cohort was investigated for changes in behavior, electrophysiology of synapse efficacy, ELISA-determined Aβ load, histopathology, and in immunoelectron microscopy”
Electrophysiology Assessment
Measure synapse efficacy and electrophysiological parameters including dentate gyrus post-tetanic potentiation and paired-pulse parameters
Note: Dentate gyrus post-tetanic potentiation was significantly attenuated at 17 months
View evidence from paper
“Dentate gyrus post-tetanic potentiation was significantly attenuated at 17 months, and there were also significant differences in paired-pulse parameters”
ELISA Analysis for Aβ Load
Determine amyloid-beta load using ELISA methodology, measuring Aβ 1-40 and Aβ 1-42 levels
Note: As early as 5 months, increased levels of insoluble Aβ were detected with Aβ 1-40 levels exceeding those of Aβ 1-42
View evidence from paper
“ELISA-determined Aβ load, histopathology, and in immunoelectron microscopy. At the same age, increased levels of insoluble Aβ were detected by ELISA, with Aβ 1-40 levels exceeding those of Aβ 1-42”
Histopathological Analysis
Perform histopathological examination to assess amyloid deposition and inflammation in brain regions
Note: Cognitive deficits first observed at 8 months when Aβ deposits and inflammation were restricted to discrete brain regions (subiculum and frontolateral cortex)
View evidence from paper
“Cognitive deficits were first observed at 8 months when Aβ deposits and inflammation were restricted to discrete brain regions, namely the subiculum and frontolateral (motor and orbital) cortex”
Immunoelectron Microscopy
Perform immunoelectron microscopy to visualize pre-plaque, immunogold-labeled extracellular fibrillar Aβ
Note: As early as 5 months, electron microscopy revealed presence of pre-plaque, immunogold-labeled extracellular fibrillar Aβ in discrete brain regions
View evidence from paper
“As early as 5 months, electron microscopy revealed the presence, in these regions, of pre-plaque, immunogold-labeled extracellular fibrillar Aβ”